The Journal of Allergy and Clinical Immunology
Volume 121, Issue 2, Supplement 2 , Pages S388-S392, February 2008

6. Secondary immunodeficiencies, including HIV infection

  • Javier Chinen, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Javier Chinen, MD, PhD, Department of Pediatrics, Allergy and Immunology Section, Baylor College of Medicine, Texas Children's Hospital, 1102 Bates St. Houston, TX 77030.
  • ,
  • William T. Shearer, MD, PhD

Department of Pediatrics, Allergy and Immunology Section, Baylor College of Medicine, Houston, Tex

Received 2 May 2007; received in revised form 4 June 2007; accepted 4 June 2007.

This activity is available for CME credit. See page 6A for important information.

The immune system can be adversely affected by a variety of extrinsic factors, including immunosuppressive drugs, exposure to harsh environmental conditions, hereditary disorders other than primary immunodeficiencies, and acquired metabolic disorders such as diabetic mellitus, with all of these resulting in conditions known as secondary immunodeficiencies. Perhaps the most well known secondary immunodeficiency is caused by HIV infection; however, the most prevalent cause of immunodeficiency worldwide is severe malnutrition, which affects as much as 50% of the population in some impoverished communities. The abnormalities of the immune system induced by secondary immunodeficiencies affect both the innate and the adaptive immunity, may be subtle, and are usually heterogeneous in their clinical manifestations. Treatment of the primary condition often results in the improvement of the compromised immune components of the disease complex. This article updates the concepts of some of the major categories of conditions that can potentially suppress the immune response, including HIV disease, to provide a conceptual frame to assess patients with suspected secondary deficiencies of the immune system.

Key words: Secondary immunodeficiency, AIDS, immunosuppression, lymphopenia

Abbreviations used: HAART, Highly active antiretroviral therapy, IRIS, Immune reconstitution inflammatory syndrome, SIV, Simian immunodeficiency virus

 

 Supported by National Institutes of Health grants AI27551, AI36211, AI6944I, HD41983, RR0188, HD79533, HL72705, and HD78522 and the David Fund, the Pediatrics AIDS Fund, and the Immunology Research Fund, Texas Children's Hospital.

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(07)01046-9

doi:10.1016/j.jaci.2007.06.003

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 2, Supplement 2 , Pages S388-S392, February 2008